Xu, X.; Jia, L.; Qiao, B.; Gong, Y.; Gao, S.; Wang, Y.; Du, J.
Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study. Metabolites 2025, 15, 64.
https://doi.org/10.3390/metabo15010064
AMA Style
Xu X, Jia L, Qiao B, Gong Y, Gao S, Wang Y, Du J.
Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study. Metabolites. 2025; 15(1):64.
https://doi.org/10.3390/metabo15010064
Chicago/Turabian Style
Xu, Xuan, Lixin Jia, Bokang Qiao, Yanyan Gong, Shan Gao, Yuan Wang, and Jie Du.
2025. "Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study" Metabolites 15, no. 1: 64.
https://doi.org/10.3390/metabo15010064
APA Style
Xu, X., Jia, L., Qiao, B., Gong, Y., Gao, S., Wang, Y., & Du, J.
(2025). Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study. Metabolites, 15(1), 64.
https://doi.org/10.3390/metabo15010064